Fluvoxamine vs Fluoxetine

How they're similar

Both are SSRIs and share class effects.

• Same broad mechanism. Both slow serotonin reuptake at the synapse, keeping more serotonin available between nerve cells.
• Same class-level side effect profile. Nausea and other stomach effects, sexual side effects (lower libido, delayed orgasm, erectile issues), increased sweating, and possible sleep changes.
• Same class safety concerns. Both can rarely contribute to serotonin syndrome when combined with other serotonin-raising drugs. Both can add to bleeding risk with NSAIDs or blood thinners. Both can lower blood sodium, more often in older adults.
• Both carry the antidepressant boxed warning about a possible increase in suicidal thoughts in people under 25, especially early in treatment or after a dose change.
• Same timeline. Full effect on mood and anxiety takes 4 to 6 weeks, sometimes up to 8. Early side effects can appear in the first week or two.
• Both are FDA-approved for OCD, which is one of the strongest overlaps between them.
• Both have been available as generics for many years.
• Both work with therapy and lifestyle interventions, not as a standalone fix.

The class-level similarities matter, but the differences below are actually where prescribers usually decide between them.

How they differ

The differences are significant enough that these two are typically chosen for different reasons.

The FDA-approval difference is a big one. Fluoxetine has broad approvals across depression, OCD, bulimia, panic disorder, and PMDD. It's approved for use in children as young as 8 for depression and 7 for OCD, making it the most commonly used SSRI in pediatric patients. Fluvoxamine's only FDA approval is for OCD, in both adults and children (starting at age 8). Off-label uses of fluvoxamine include depression and various anxiety disorders, but the studies and clinical experience there aren't as deep as with fluoxetine.

Half-life is a defining difference. Fluoxetine has the longest half-life of any SSRI. The parent drug hangs around for one to four days. Its active metabolite, norfluoxetine, has a half-life of 7 to 15 days. That gives fluoxetine a built-in self-taper. If someone stops it, blood levels come down slowly on their own, and discontinuation symptoms are minimal or absent. That's a real advantage for people who might miss doses or struggle with a clean taper later. It's also why fluoxetine is often used to bridge someone off a shorter-acting antidepressant, taking over for a week or two before stopping.

Fluvoxamine's half-life is much shorter, around 15 to 22 hours. Discontinuation symptoms can appear if doses are missed. Stopping needs a real taper.

Drug interactions are one of the biggest reasons to choose or avoid each drug.

Fluvoxamine is a strong inhibitor of CYP1A2. That single fact drives a lot of prescribing decisions. Clozapine levels can rise dramatically with fluvoxamine, sometimes to toxic levels, so combining them requires very careful dosing (sometimes fluvoxamine is used deliberately to raise clozapine levels when needed, but it's a specialist decision). Caffeine metabolism is slowed, so people can feel much more effect from smaller amounts of coffee. Theophylline, tizanidine, and ramelteon levels all rise significantly. Some tricyclic antidepressants (like amitriptyline) reach higher levels. Fluvoxamine also inhibits CYP2C19 and CYP3A4, adding to the interaction list.

Fluoxetine's key interaction is through CYP2D6, which it inhibits strongly. That matters for a lot of medications. Tricyclic antidepressants reach much higher levels when combined with fluoxetine. Some antipsychotics, including risperidone and aripiprazole, are affected. The tamoxifen interaction is important for women who take tamoxifen for breast cancer or breast cancer prevention. Tamoxifen needs to be converted to its active form by CYP2D6, and fluoxetine (like paroxetine and bupropion) blocks that conversion. Oncologists usually recommend avoiding fluoxetine in tamoxifen users. Fluoxetine has mild effects on CYP3A4 too.

Dosing shape is different. Fluvoxamine can be dosed once daily at lower doses, but at doses above 100 mg per day the recommendation is to split it into twice daily to reduce peak-related side effects. Many people take fluvoxamine at bedtime because it's sedating.

Fluoxetine is once daily, usually in the morning because it's activating. Some people feel jittery, wired, or have trouble sleeping in the first week or two. Taking it earlier in the day helps. The activating quality can be useful for depression with low energy but can worsen anxiety in the short term.

Side effect tendencies

Fluoxetine's activating quality is the first thing to notice. Some people feel jittery, restless, or anxious in the first one to two weeks. Sleep can be disrupted early on. For most people this eases within two weeks. For some it persists and is a reason to switch or lower the dose. In people with depression and low energy, the activating quality can be an advantage.

Fluvoxamine tends toward sedation. Taking it at bedtime helps use that effect rather than fight it. Nausea is more prominent with fluvoxamine early on and is one of the more common reasons people struggle with it in the first weeks. Splitting the dose or taking it with food helps.

Sexual side effects happen with both, and are a common reason people struggle with any SSRI long-term. Lower sex drive, delayed orgasm, and arousal difficulties are common with both. These effects tend to last as long as the medication is taken, rather than fading. Options include dose adjustment, a switch to a different antidepressant (bupropion, mirtazapine), or adding bupropion alongside the SSRI.

Weight-wise, both are roughly weight-neutral in the short term. With long-term use, modest weight gain is possible on either drug.

Discontinuation syndrome is where the two really differ. Fluoxetine's long half-life gives it a built-in taper. Even missing several doses usually causes no withdrawal effects. Fluvoxamine's shorter half-life means missed doses or abrupt stops can produce dizziness, brain zaps, irritability, and flu-like symptoms.

Serotonin syndrome, hyponatremia, and increased bleeding risk are shared class effects.

QT prolongation is not a major concern with either drug, unlike citalopram at higher doses.

What tips the choice

Because these two are used for different situations, the choice usually depends on what's being treated and what other medications are on board.

Fluoxetine is often chosen for depression, especially in adolescents where it's the SSRI with the strongest pediatric evidence. It's often chosen for OCD when someone is expected to have trouble with a clean taper down the road, since the long half-life self-tapers. It's a reasonable pick for panic disorder, bulimia, and PMDD given the formal approvals. Its activating quality can suit someone with depression and low motivation.

Fluvoxamine is often chosen specifically for OCD, especially when a prior SSRI hasn't worked. Some clinicians use it deliberately for its sedating quality when insomnia is part of the picture. It's occasionally used to raise clozapine levels in a controlled way, which is a specialist decision.

Drug interactions rule out one or the other for many patients. Someone taking tamoxifen shouldn't take fluoxetine. Someone taking clozapine, tizanidine, ramelteon, or theophylline usually shouldn't take fluvoxamine unless the interaction is deliberate and carefully managed. Someone on multiple other medications should have interactions carefully reviewed before either drug is started.

Prior response carries weight. If a person did well on one before, that's often the one to return to. If a family member responded well to one, that can nudge the choice.

Activating vs sedating profile matters based on symptoms. Depression with fatigue and low motivation may pair better with fluoxetine. Depression with anxiety and insomnia may pair better with fluvoxamine.

Pediatric use is another factor. Fluoxetine has the deepest pediatric evidence base of any SSRI. Fluvoxamine is approved for pediatric OCD but is used less often than fluoxetine or sertraline in that setting.

Common questions

Is one of these better for OCD? Both are FDA-approved for OCD, and both are effective. In head-to-head trials the response rates look broadly similar. Fluoxetine has the advantage of once-daily dosing and easy discontinuation. Fluvoxamine has the disadvantage of more drug interactions but is sometimes tried when fluoxetine hasn't worked. Some clinicians consider fluvoxamine specifically SSRIs studied for OCD, which is why it's sometimes preferred despite the interaction issues.

Why does the caffeine warning matter with fluvoxamine? Fluvoxamine strongly inhibits CYP1A2, the enzyme that breaks down caffeine. On fluvoxamine, one cup of coffee can feel like three or four cups. People may notice increased jitteriness, palpitations, or trouble sleeping if they don't reduce caffeine intake. It's worth cutting back on coffee, tea, and energy drinks after starting fluvoxamine, and being cautious with medications that also affect CYP1A2.

Can I switch between fluoxetine and fluvoxamine? Yes, and it's occasionally done for OCD when one hasn't worked well. Switching from fluoxetine takes some planning because of its long half-life. If someone stops fluoxetine and starts fluvoxamine, the fluoxetine is still around for weeks, which can complicate interactions. A washout period, or a careful cross-taper, is done under a prescriber's guidance.

Which one causes more sexual side effects? Both cause sexual side effects at similar rates. This is one of the most common frustrations with any SSRI. Effects can include lower libido, delayed orgasm, and difficulty with arousal or erection. If this is a major concern, options include dose reduction, switching to a different antidepressant (like bupropion or mirtazapine), or adding bupropion. It's worth talking about with a prescriber rather than stopping the medication on your own.

Is Prozac safer than Luvox? Neither is safer overall. They have different profiles. Fluoxetine has fewer drug interactions and less discontinuation syndrome. Fluvoxamine has more interactions but sometimes suits a specific patient better. Both are FDA-approved and widely used. Safety depends on the individual, other medications, and the condition being treated.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes. This is not medical advice.

1. U.S. Food and Drug Administration. Fluoxetine prescribing information.
2. U.S. Food and Drug Administration. Fluvoxamine prescribing information.
3. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder.
4. MedlinePlus, U.S. National Library of Medicine.